News & Trends

• 28 2024-11

  Salubris’innovative drugs Xinliting and FoLitan ® ...
• 27 2024-08

  Salubris obtaining the exclusive right of base edi...
• 05 2024-08

  The innovative anti-tumor drug JK06 was approved f...
• 01 2024-08

  Enarodustat’s new indication approved for clinical...
• 31 2024-07

  SAL0120 tablets for treatment of chronic kidney di...